News

Media

Conferences

Publications

Clinical

Events

Resources

What Does the Future Hold for Biosimilars in the United States?

August 25, 2015

By Davy James, Managing Editor

Video

Marc O'Connor, Chief Operating Officer of Curant Health, discusses the potential impact of biosimilars on the specialty drug market.

Marc O'Connor, Chief Operating Officer of Curant Health, discusses the potential impact of biosimilars on the specialty drug market.

Recent Videos

Naloxone concept represented by wooden letter tiles.

Hand holding a Narcan Evzio Naloxone nasal spray opioid drug overdose prevention medication

Image credit: Gorodenkoff | stock.adobe.com

Pharmacist and Patient in Pharmacy | Image Credit: Gorodenkoff - stock.adobe.com

Sun Screen, Photosensitivity, Pharmacy | Image Credit: sosiukin - stock.adobe.com

Catalyst Trial, Diabetes, Hypertension | Image Credit: grinny - stock.adobe.com

Image Credit: © Anastasiia - stock.adobe.com

Consent Preferences

Clinical Forums

Editorial Staff

Terms & Conditions

Do Not Sell My Information

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

© 2024 MJH Life Sciences

All rights reserved.